A systematic review of the effect of semaglutide on lean mass: insights from clinical trials-Reference-Cited by-同舟云学术

A systematic review of the effect of semaglutide on lean mass: insights from clinical trials

Published:2024-03-23 Issue:5 Volume:25 Page:611-619
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Bikou Alexia¹,Dermiki-Gkana Foteini¹,Penteris Michail¹,Constantinides Theodoros K¹,Kontogiorgis Christos¹

Affiliation:

1. Laboratory of Hygiene and Environmental Protection, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2343092

Reference54 articles.

1. World_Obesity_Atlas_2022.

2. European Guidelines for Obesity Management in Adults

3. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

4. World Health Organization. A healthy lifestyle - WHO recommendations. 2010. https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle---who-recommendations

5. Updates on obesity pharmacotherapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is semaglutide a target therapy for acquired hypothalamic obesity?;Pituitary;2024-08-30

2. Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study;Clinical Infectious Diseases;2024-07-24

3. Why you should not skip tailored exercise interventions when using incretin mimetics for weight loss;Frontiers in Endocrinology;2024-07-23

4. Anti-obesity medications in the management of heart failure with preserved ejection fraction: available evidence and next STEPS;Heart Failure Reviews;2024-07-04